DMC1: A Potential Drug Target and Biomarker (G11144)

Target Name: DMC1

NCBI ID: G11144

DMC1

DMC1: A Potential Drug Target and Biomarker

DMC1, also known as DMC1 homologue, is a protein that is expressed in various tissues and organs in the body. It is a key regulator of cell division and has been implicated in the development and progression of various diseases, including cancer. In this article, we will discuss the potential implications of DMC1 as a drug target and biomarker.

The discovery of DMC1

DMC1 was first identified in the late 1990s by researchers at the University of California, San Diego. They were studying the factors that regulate cell division in the laboratory and noticed that a protein called DMC1 was highly expressed in various tissues and organs. They then used RNA interference to knock down the expression of DMC1 in cancer cells and observed that the cells began to undergo a rapid cycle of division, suggesting that DMC1 may be involved in cell division.

Subsequent studies revealed that DMC1 was not only involved in cell division but also in the regulation of cell growth and the control of apoptosis, or cell death. DMC1 was shown to be regulated by various factors, including the TGF-β pathway, which is a well-known regulator of cell growth and differentiation.

DMC1 as a drug target

DMC1's involvement in cell division and growth makes it an attractive target for drug development. One of the main advantages of targeting DMC1 is that it does not require a specific mechanism of action, which makes it less likely to cause unintended side effects. Additionally, because DMC1 is widely expressed in various tissues and organs, targeting it is less likely to be limited by specificity.

DMC1 has been shown to play a role in the development and progression of various diseases, including cancer. By targeting DMC1, researchers have been able to inhibit its activity and observe a reduction in cell division and growth. This has led to the possibility that DMC1 may be an effective target for cancer treatments.

DMC1 as a biomarker

DMC1 has also been shown to be a potential biomarker for various diseases, including cancer. Its involvement in cell division and growth makes it a potentially useful marker for tracking disease progression and response to treatment.

One of the main advantages of using DMC1 as a biomarker is that it is highly expressed in various tissues and organs, which makes it more reliable than some other biomarkers. Additionally, because DMC1 is involved in the regulation of cell growth and apoptosis, it may be a useful marker for tracking the effectiveness of different treatments.

Conclusion

In conclusion, DMC1 is a protein that has been shown to be involved in the regulation of cell division and growth, and its potential as a drug target and biomarker make it an attractive target for further research. Further studies are needed to fully understand the role of DMC1 in disease progression and the development of cancer.

Protein Name: DNA Meiotic Recombinase 1

Functions: Participates in meiotic recombination, specifically in homologous strand assimilation, which is required for the resolution of meiotic double-strand breaks

The "DMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets